|
Video: What is a Stock Split?
|
|
Oncternal Therapeutics is a biopharmaceutical company engaged in the discovery, development and commercialization medicines to treat medical conditions, including stress urinary incontinence and prostate cancer. Co. is focused on the further development of selective androgen receptor modulators (SARMs), including its primary product candidate, enobosarm (GTx-024). SARMs is a class of drugs that has the potential to treat serious medical conditions such as stress urinary incontinence. Co. is also evaluating enobosarm and other compounds in its SARM portfolio for indications outside of oncology. According to our GTXI split history records, GTXI has had 1 split. | |
|
GTXI (GTXI) has 1 split in our GTXI split history database. The split for GTXI took place on December 06, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of GTXI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as GTXI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the GTXI split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GTXI shares, starting with a $10,000 purchase of GTXI, presented on a split-history-adjusted basis factoring in the complete GTXI split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
06/06/2019 |
|
Start price/share: |
$13.60 |
|
End price/share: |
$1.20 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-91.18% |
|
Average Annual Total Return: |
-37.77% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$882.53 |
|
Years: |
5.12 |
|
|
|
Date |
Ratio |
12/06/2016 | 1 for 10 |
|
|